Directory

>

Justin To

avatar

Justin To

CEO, Skeletal Dysplasias (QED Therapeutics) | BridgeBio

San Francisco, California, United States

View contact details (it's free)

Justin To

Summary

Justin To is an accomplished CEO at QED Therapeutics, a subsidiary of BridgeBio, specializing in the development of innovative therapies for skeletal dysplasias. With a robust background in biochemistry and molecular biology, Justin has effectively transitioned from consulting at McKinsey to leading major operations in the biotech sector. His leadership experience spans several high-level roles at BridgeBio, where he has driven strategic initiatives in gene therapy and business development. Justin's educational foundation from Harvard University in Chemistry complements his extensive expertise in biotechnology. He is known for his adaptability in fast-paced environments and his commitment to advancing medical science. Outside of his professional pursuits, Justin is passionate about fostering innovation in healthcare and mentoring emerging leaders in the industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Justin To

Work Experience

company logo

CEO, Skeletal Dysplasias (QED Therapeutics) at

BridgeBio

January 2024 - Present

company logo

Chief Operating Officer, Skeletal Dysplasias and Gene Therapy at

BridgeBio

September 2022 - January 2024

company logo

Chief Operating Officer, Gene Therapy at

BridgeBio

September 2020 - November 2022

company logo

Vice President of Business Development and Operations, Gene Therapy at

BridgeBio

March 2018 - September 2020

company logo

Associate Director of Portfolio Management at

BridgeBio

August 2017 - March 2018

company logo

Product Commercialization at

Flatiron Health

June 2016 - July 2017

company logo

Consultant at

McKinsey & Company

August 2014 - May 2016

Logos provided by Logo.dev

Justin To

Education

Frequently Asked Questions about Justin To

What is Justin To email address?

Justin To's primary email address is ***@bridgebio.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Justin To work for?

Justin To is a CEO, Skeletal Dysplasias (QED Therapeutics) at BridgeBio, a company specializing in Commercial physical research.

Where Justin To graduated from?

Justin To holds a degree in Chemistry from Harvard University.

How can I directly contact Justin To?

To contact Justin To directly, you can use the email address ***@bridgebio.com. Complete contact information is available upon registration with Muraena.

Who is Justin To?

Justin To is an accomplished CEO at QED Therapeutics, a subsidiary of BridgeBio, specializing in the development of innovative therapies for skeletal dysplasias. With a robust background in biochemistry and molecular biology, Justin has effectively transitioned from consulting at McKinsey to leading major operations in the biotech sector. His leadership experience spans several high-level roles at BridgeBio, where he has driven strategic initiatives in gene therapy and business development. Justin's educational foundation from Harvard University in Chemistry complements his extensive expertise in biotechnology. He is known for his adaptability in fast-paced environments and his commitment to advancing medical science. Outside of his professional pursuits, Justin is passionate about fostering innovation in healthcare and mentoring emerging leaders in the industry.

Justin`s contact details

mail

***@bridgebio.com

Colleagues

avatar
Scott Collins

Senior Vice President - Head of Market Access - BridgeBio

avatar
Rohit Chawla

Vice President, Head of Program Management

avatar
Thomas Gnielinski

VP Law, Associate General Counsel

Morgan Paull

SVP of Strategy and Operations

avatar
Sean Doherty

Senior Vice President Marketing

avatar
Courtney Grafe

Vice President, Talent

avatar
Sun-Gou Ji

Vice President, Computational Genomics

avatar
Amy Thompson

Vice President Supply Chain Management

View Contact details (it's free)
Request Profile Removal